Type 2 Diabetes: How Thiazolidinediones Fit In
Type 2 Diabetes: How Thiazolidinediones Fit In
The Big Picture
Type 2 diabetes is a common condition, and thiazolidinediones are one of the treatment options available. Let's examine their role in managing this disease.
Contents
What Are Thiazolidinediones?
Thiazolidinediones are a class of medications used to improve insulin sensitivity in people with type 2 diabetes. They help the body better utilize glucose, which can lower blood sugar levels. Pioglitazone is currently the most common thiazolidinedione available.
When Are They Used?
These medications are usually considered when other treatments haven't worked. They are not typically the first choice but can be useful for patients who can't tolerate other diabetes medications. Doctors often consider them when cost is a concern, as some thiazolidinediones are available as generics.
Side Effects to Watch For
While effective, thiazolidinediones can cause side effects such as weight gain and an increased risk of heart failure. Patients should be aware of these and work closely with their healthcare provider to monitor for any adverse effects.
FAQs
What is type 2 diabetes?
Type 2 diabetes is a condition where the body can't properly use insulin.
How do thiazolidinediones help manage diabetes?
They improve insulin sensitivity and help lower blood sugar levels.
When are thiazolidinediones prescribed?
They're used when other diabetes medications haven't worked.
Are there side effects to be aware of?
Yes, including weight gain and heart failure risk.
Is pioglitazone a thiazolidinedione?
Yes, pioglitazone is a common thiazolidinedione.
Wrapping Up
Thiazolidinediones can be effective for managing type 2 diabetes but come with their own set of challenges.
Additional References
- Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355:2427.
- Phillips LS, Grunberger G, Miller E, et al. Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes. Diabetes Care 2001; 24:308.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.